Table 1.
The various tests for chronic tubular dysfunction in diabetic nephropathy
Test name | Use |
Blood urea nitrogen (serum or plasma) | Initial diagnosis of acute or chronic kidney disease |
Method: Spectrophotometry | |
Creatinine (serum or plasma) | Initial diagnosis of acute or chronic kidney disease |
Method: Spectrophotometry | |
Microalbumin (urine) | May be used as a screening test |
Method: Immunoturbidimetric | Useful in diabetic patients to assess baseline renal function |
Useful in monitoring diabetic nephropathy in insulin-dependent diabetes mellitus | |
Creatinine based glomerular filtration rate (estimated) | Estimate renal function and use as monitoring tool |
Method: Spectrophotometry | (Test reports serum creatinine reference intervals) |
Cystatin-C based glomerular filtration rate (estimated) | May be useful sensitive marker of renal disease; however, test lacks specificity due to reference range inavailability |
Method: Nephelometry | |
Retinol-binding protein 4 (RBP4) | May be used as a marker for early diabetic nephropathy. Limited studies are available |
Method: Non-commercial enzyme-linked immunosorbant assay (ELISA) | |
Adiponectin | Shown inverse correlation with renal dysfunction in type 2 diabetes |
Method: Competitive radioimmunoassay | |
Connective tissue growth factor (CTGF) | CTGF excretion is correlated inversely with GFRs |
Method: ELISA | |
Alpha-1-microglobulin (urine) | May indicate renal involvement in diabetic patients |
Method: Nephelometry | |
Liver type fatty acid binding protein (L-FABP) | Expressed in proximal tubular cells and may associated with severity of diabetic nephropathy. Larger conclusive studies are required |
Method: ELISA |